Re-review completed for `doi__10.3390_ph3123594`.

Outcome: `accepted_with_cautions`, `publication_grade=true`, no open rework targets or QC failures. I closed `rwk-complete-test-0001` via `paper_packets/doi__10.3390_ph3123594/rework/rework_responses.jsonl`.

What changed:
- Worker-2: recovered `13` source-supported activity/toxicity rows from local XML/PDF prose and figure captions.
- Worker-4: adjudicated `3` DRAMP-linked rows: `2 source_conflict`, `1 source_verified`.
- Worker-6: updated final adjudication/review, quality feedback, packet manifest/status, and complete report.

Validation:
- `semantic_three_layer_gate.py`: `pass=1`, `fail=0`, `issues=[]`
- `check_three_layer_publication_quality.py`: `publication_grade_pass=true`, `risk_counts={}`

Key caution preserved: DRAMP labels VPTLK/Bip2 as antimicrobial/anticancer, but the primary paper supports CPP5 cell entry, cytotoxicity/cytoprotection, uptake, and protein transduction, not MIC/antimicrobial or anticancer killing assays. I preserved that as `source_conflict` rather than fabricating rows.

